Results 121 to 130 of about 1,869 (168)

Update of the evidence- and consensus-based S3 guideline on atopic dermatitis: Systemic therapy with biologics or Janus kinase inhibitors and specific aspects of systemic therapy in pregnancy and lactation. [PDF]

Allergol Select
Werfel T, Heratizadeh A, Augustin M, Bangert C, Bauer A, Biedermann T, Brans R, Domröse N, Gieler U, Gießler-Fichtner O, Hamelmann E, Hampe S, Heuer R, Kahle J, Kinberger M, Koch M, Köhler M, Legat F, Nemat K, Neustädter I, Peters EMJ, Radonjic-Hoesli S, Reese I, Schmid-Grendelmeier P, Schmidt-Göhrich UK, Schmitt J, Schnopp C, Schwennesen T, Simon D, Stamos K, Termeer C, Treudler R, von Kiedrowski R, Wagner I, Waßmann-Otto A, Weckmann G, Werner RN, Wollenberg A, Worm M, Ott H.   +39 more
europepmc   +1 more source

Biologic Monotherapies for Moderate-to-Severe Atopic Dermatitis: A Systematic Review and Bayesian Network Meta-Analysis of Established and Investigational Agents. [PDF]

Cureus
Babul A, Mehta D, Soliman Y, Hussain M, Babul N.   +4 more
europepmc   +1 more source

Comparing the Efficacy and Safety of Nemolizumab Versus Anti-interleukin Monoclonal Antibody Therapies in Combination with Topical Treatments for Moderate-to-Severe Atopic Dermatitis Using Network Meta-analysis. [PDF]

Dermatol Ther (Heidelb)
Pink AE, Houghton J, White H, Schiavo S, Piketty C, Ulianov L, Rout R, Jack K, Subramanian R, Puelles J.   +9 more
europepmc   +1 more source

A Response to "Letter to the Editor Regarding 'Dupilumab Versus Lebrikizumab Demonstrates Greater Likelihood of Achieving and Maintaining Improvements in Efficacy Outcomes Using a Placebo-Adjusted Indirect Treatment Comparison'". [PDF]

Dermatol Ther (Heidelb)
Ständer S, Pinter A, Hougeir FG, Guyot P, Xu Y, Praestgaard AH, Freemantle N, Rossi AB, Bégo-Le-Bagousse G, Wang Z, Noonan K, Bastian M.   +11 more
europepmc   +1 more source

Comparative efficacy and safety of biologic therapies in pediatric asthma: a comprehensive systematic review. [PDF]

Front Med (Lausanne)
Alzayed A.
europepmc   +1 more source

Mycosis fungoides unmasked during lebrikizumab treatment

JAAD Case Reports
Isabel C. Yoon, Leah Cohen, Jina Chung, Ellen J. Kim   +3 more
openaire   +1 more source

Real-world effectiveness and safety of lebrikizumab maintenance dosing every 4 weeks starting at week 4 after 2 loading doses in Japanese patients with atopic dermatitis. [PDF]

JAAD Int
Okada Y, Kamata M, Suzuki S, Watanabe A, Chijiwa C, Tomura Y, Takeshima R, Hiura A, Hayashi K, Fukuyasu A, Tanaka T, Ishikawa T, Tada Y.   +12 more
europepmc   +1 more source

Efficacy of abrocitinib in patients with atopic dermatitis resistant to Janus kinase inhibitors. [PDF]

Skin Health Dis
Ippoliti E, Gori N, Coscarella G, Antonelli F, Cannizzaro MV, Peris K.   +5 more
europepmc   +1 more source

State-of-the-Art Review: Vaccination in Pediatric Dermatology Patients Receiving Immunosuppressive or Immunomodulatory Therapy: A Review. [PDF]

Pediatr Dermatol
Elaiho CR, Kumar A, Barry K, Berce P, Humphrey SR.   +4 more
europepmc   +1 more source

Stapokibart (CM310) in Atopic Dermatitis: A Narrative Review of a Next-Generation IL-4Rα Antagonist. [PDF]

Dermatol Pract Concept
Ferreira E, Wu T, Chen Y.
europepmc   +1 more source